CAS 1446263-39-3

1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-[(2E)-3-bromo-2-buten-1-yl]-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-

CAS: 1446263-39-3

Formula: C₂₅H₂₉BrN₈O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 553.4542

Ref: IN-DA00ABGQ

(R,E)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

CAS: 1446263-39-3

(R,E)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

Purity: 98%

Molecular weight: 553.45g/mol

Ref: 54-OR1075520

(R,E)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

CAS: 1446263-39-3

Purity: 98%

Molecular weight: 553.4650268554688

Ref: 10-F789857

Linagliptin Impurity 114

CAS: 1446263-39-3

Formula: C₂₅H₂₉BrN₈O₂

Molecular weight: 553.47

Ref: 4Z-L-44131

N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin (E/Z Mixture)

CAS: 1446263-39-3, 1638744-06-5

Applications N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin is an impurity of Linagliptin (L465900); a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
References Prabavathy, N. et al.: Int. J. Pharm. Bio. Sci., 2, 438 (2011); Deacon, C.F.: Diab. Obes. Metab., 13, 7 (2011)

Formula: C₂₅H₂₉BrN₈O₂

Color and Shape: Neat

Molecular weight: 553.45

Ref: TR-D282015

Linagliptin Bromo Impurity

CAS: 1446263-39-3

Formula: C₂₅H₂₉BrN₈O₂

Molecular weight: 553.47

Ref: ST-EA-CP-L1022